Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
BlueSphere Bio
Sort By
Newest First
1 / 1
1 / 1
Cell Therapy
Fighting Solid Tumors by Targeting Neoantigens in a Personalized Manner
Mark Shlomchik, M.D., Ph.D.
BlueSphere Bio
PAO-06-022-CL-03
June 06, 2022
Leadership
Q: What’s the key to being a leader in the industry?
Pharma's Almanac
PAO-03-022-RT-02
March 11, 2022
Milestones
Q: What important company milestone do you anticipate reaching in 2022?
Pharma's Almanac
PAO-03-022-RT-01
March 11, 2022
